Skip to main content
. Author manuscript; available in PMC: 2019 Jan 22.
Published in final edited form as: J Neurooncol. 2017 Mar 17;132(3):513–519. doi: 10.1007/s11060-017-2404-1

Fig. 2.

Fig. 2

Mean brain visipaque contrast uptake with varied conditions. Regadenoson poses little effect on contrast enhancement within the brain 20 min after administration (P = 0.13)